Detecting neuroendocrine prostate cancer through tissue-informed cell-free DNA methylation analysis

JE Berchuck, SC Baca, HM McClure, K Korthauer… - Clinical Cancer …, 2022 - AACR
Purpose: Neuroendocrine prostate cancer (NEPC) is a resistance phenotype that emerges
in men with metastatic castration-resistant prostate adenocarcinoma (CR-PRAD) and has …
被引用次数：35 相关文章

Detecting Neuroendocrine Prostate Cancer Through Tissue-Informed Cell-Free DNA Methylation Analysis

JE Berchuck, SC Baca, HM McClure… - … : an official journal …, 2022 - pubmed.ncbi.nlm.nih.gov
Purpose Neuroendocrine prostate cancer (NEPC) is a resistance phenotype that emerges in
men with metastatic castration-resistant prostate adenocarcinoma (CR-PRAD) and has …

Detecting Neuroendocrine Prostate Cancer Through Tissue-Informed Cell-Free DNA Methylation Analysis

JE Berchuck, SC Baca, HM Mcclure… - CLINICAL CANCER …, 2022 - fair.unifg.it
Purpose: Neuroendocrine prostate cancer (NEPC) is a resistance phenotype that emerges
in men with metastatic castration-resistant prostate adenocarcinoma (CR-PRAD) and has …

Detecting Neuroendocrine Prostate Cancer Through Tissue-Informed Cell-Free DNA Methylation Analysis.

JE Berchuck, SC Baca, HM McClure… - … Cancer Research: an …, 2022 - europepmc.org
Purpose Neuroendocrine prostate cancer (NEPC) is a resistance phenotype that emerges in
men with metastatic castration-resistant prostate adenocarcinoma (CR-PRAD) and has …

Detecting Neuroendocrine Prostate Cancer Through Tissue-Informed Cell-Free DNA Methylation Analysis

JE Berchuck, SC Baca, HM McClure, K Korthauer… - Clinical Cancer …, 2022 - AACR
Purpose: Neuroendocrine prostate cancer (NEPC) is a resistance phenotype that emerges
in men with metastatic castration-resistant prostate adenocarcinoma (CR-PRAD) and has …
[HTML] nih.gov

[HTML][HTML] Detecting neuroendocrine prostate cancer through tissue-informed cell-free DNA methylation analysis

JE Berchuck, SC Baca, HM McClure… - … cancer research: an …, 2022 - ncbi.nlm.nih.gov
Purpose: Neuroendocrine prostate cancer (NEPC) is a resistance phenotype that emerges
in men with metastatic castration-resistant prostate adenocarcinoma (CR-PRAD) and has …
[PDF] researchgate.net

[PDF][PDF] Detecting neuroendocrine prostate cancer through tissue-informed cell-free DNA 1 methylation analysis 2 3

JE Berchuck, SC Baca, HM McClure - researchgate.net
Purpose: Neuroendocrine prostate cancer (NEPC) is a resistance phenotype that emerges
in men 41 with metastatic castration-resistant prostate adenocarcinoma (CR-PRAD) and has …

Detecting Neuroendocrine Prostate Cancer Through Tissue-Informed Cell-Free DNA Methylation Analysis.

JE Berchuck, SC Baca, HM McClure… - … Cancer Research: an …, 2022 - europepmc.org
Purpose Neuroendocrine prostate cancer (NEPC) is a resistance phenotype that emerges in
men with metastatic castration-resistant prostate adenocarcinoma (CR-PRAD) and has …